Cagrilintide ZPHC — 25 mg

by ZPHC

Cagrilintide 25mg by ZPHC. Long-acting amylin analogue for weight research.

Purity (HPLC): 99%+
Tested by: ZPHC

In stock

Quantity

Pay with Bitcoin or USDT (TRC-20) on this site, or contact a representative for a card or bank payment link. Free EU shipping over €250.

Batch certificate of analysis available on request via Telegram or the contact form.

Research overview

ZPHC Cagrilintide 25mg is a long-acting amylin analogue designed for once-weekly dosing, studied in combination with semaglutide as the CagriSema protocol. Amylin, co-secreted with insulin, acts in the hypothalamus to reduce appetite, slow gastric emptying and inhibit glucagon secretion; cagrilintide extends these actions to approximately 7 days via fatty acid chain modification. Phase 3 REDEFINE 1 CagriSema trial data demonstrated up to 22.7% weight reduction — approaching or exceeding results from any single-agent anti-obesity compound.

EU stock, ZPHC GMP-grade production, Janoshik-verified 99%+ purity. For laboratory research use only.

Specifications

Compound: Cagrilintide ZPHC — 25 mg
Purity: 99%+ (HPLC)
Tested by: ZPHC
Brand: ZPHC
Category: Weight Loss
Storage: Lyophilised: store at 2–8°C, away from light. Follow the label after reconstitution
Intended use: In-vitro and laboratory research only
Shipping: EU, tracked, dispatched within 48 hours of payment

Research use only. All products are sold strictly for in-vitro and laboratory research. Not for human consumption, veterinary use, diagnosis, treatment or prevention of any disease. Must be handled by qualified professionals in a controlled laboratory setting. JuicedPharma makes no therapeutic or medical claims about this compound.